Skip to main content
Top
Published in: Lung 5/2016

01-10-2016

The Association of Brain-Derived Neurotrophic Factor Gene Polymorphism with Obstructive Sleep Apnea Syndrome and Obesity

Authors: Mehmet Yüksekkaya, Nuri Tutar, Hakan Büyükoğlan, Munis Dündar, İnsu Yılmaz, İnci Gülmez, Fatma Sema Oymak, Burhan Balta, Keziban Korkmaz, Ramazan Demir

Published in: Lung | Issue 5/2016

Login to get access

Abstract

Background

Obesity represents a major risk factor for Obstructive Sleep Apnea Syndrome (OSAS). Brain-derived neurotrophic factor (BDNF) affects the mechanisms that regulate weight, eating behavior, and metabolism. This project aims to investigate the possible association of BDNF gene polymorphism with obesity and OSAS, and to contribute knowledge to the understanding of the pathophysiology of OSAS.

Methods

The subjects included in this study were selected among the individuals who were hospitalized in the Erciyes University Medical School Chest Diseases Sleep Medicine Laboratory. Subjects were divided into four groups based on the presence of OSAS and/or obesity. Group 1 included OSAS+ obesity+ patients, Group 2 included OSAS+ obesity− patients, Group 3 included OSAS− obesity+ patients, and Group 4 included OSAS− obesity− patients. The targeted patient number per each study group was 45, but only 32 patients could be enrolled into Group 3.

Results

Out of a total number of 167 subjects, 117 (70.1 %) had BDNF 196G/G, 48 (28.7 %) had BDNF 196G/A, and 2 (1.2 %) had BDNF 196A/A genotype. Of 48 subjects having BDNF 196G/A genotype, 32 (66.6 %) were obese, and 16 (33.3 %) were non-obese. Out of 90 subjects with OSAS, 64 (71.1 %) had BDNF 196G/G, and 25 (27.8 %) had BDNF 196G/A genotype. Out of 77 subjects without OSAS, BDNF 196G/G, and BDNF 196G/A genotypes were detected in 53 (68.8 %) and 23 (29.9 %) subjects, respectively. A statistically significant difference was demonstrated between the four study groups in terms of BDNF rs6265 polymorphism (p = 0.013). This difference was attributed to OSAS+ obesity− Group, in which BDNF 196G/G genotype was more common and BDNF 196G/A polymorphism was less common than the patients in other groups.

Conclusion

In conclusion, BDNF 196G/A genotype was found to be more frequent among obese patients compared to the non-obese individuals, but it was not significantly related to OSAS in the present study. BDNF196G/G genotype was more common and BDNF 196G/A polymorphism was less common among OSAS+ obesity- subjects compared to the other study groups.
Literature
1.
go back to reference Schwab RJ, Pack AL (1998) Fishman’s pulmonary diseases and disorders. Mc Graw-Hill Book Company, New York, pp 1617–1637 Schwab RJ, Pack AL (1998) Fishman’s pulmonary diseases and disorders. Mc Graw-Hill Book Company, New York, pp 1617–1637
2.
go back to reference Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235CrossRefPubMed
3.
go back to reference Mortimore IL, Marshall I, Wraith PK et al (1998) Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 157:280–283CrossRefPubMed Mortimore IL, Marshall I, Wraith PK et al (1998) Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 157:280–283CrossRefPubMed
4.
go back to reference Schwartz AR, Patil SP, Laffan AM et al (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192CrossRefPubMedPubMedCentral Schwartz AR, Patil SP, Laffan AM et al (2008) Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 5:185–192CrossRefPubMedPubMedCentral
5.
go back to reference Lindsay R, Wiegand S, Altar C et al (1994) Neurotrophic factors: from molecule to man. Trends Neurosci 17:182–190CrossRefPubMed Lindsay R, Wiegand S, Altar C et al (1994) Neurotrophic factors: from molecule to man. Trends Neurosci 17:182–190CrossRefPubMed
6.
go back to reference Lommatzsch M, Zingler D, Schuhbaeck K et al (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123CrossRefPubMed Lommatzsch M, Zingler D, Schuhbaeck K et al (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123CrossRefPubMed
7.
go back to reference Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229–238CrossRefPubMed Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229–238CrossRefPubMed
8.
go back to reference Thorleifsson G, Walters GB, Gudbjartsson DF et al (2009) Genomewide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41:18–24CrossRefPubMed Thorleifsson G, Walters GB, Gudbjartsson DF et al (2009) Genomewide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41:18–24CrossRefPubMed
9.
10.
go back to reference Wang Y, Wang JJ, Zhao MQ et al (2010) Regulation of BDNF in obstructive sleep apnoea. J Int Med Res 38:1942–1951CrossRefPubMed Wang Y, Wang JJ, Zhao MQ et al (2010) Regulation of BDNF in obstructive sleep apnoea. J Int Med Res 38:1942–1951CrossRefPubMed
11.
go back to reference World Health Organization Expert Committee: Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series No: 854. Geneva, World Health Organization 1995 World Health Organization Expert Committee: Physical Status: The Use and Interpretation of Anthropometry. WHO Technical Report Series No: 854. Geneva, World Health Organization 1995
12.
go back to reference Rechtschaffen AK (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda: National Institute for Neurological Disease and Blindness. Report No: NIH 204 [PubMed] Rechtschaffen AK (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda: National Institute for Neurological Disease and Blindness. Report No: NIH 204 [PubMed]
13.
go back to reference Sleep-related breathing disorders in adults (1999) Recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689 Sleep-related breathing disorders in adults (1999) Recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689
14.
go back to reference World Health Organization (2011) Waist circumference & waist-hip ratio. World Health Organization, Geneva, pp 5–23 World Health Organization (2011) Waist circumference & waist-hip ratio. World Health Organization, Geneva, pp 5–23
15.
go back to reference Gunstad J, Schofield P, Paul RH et al (2006) BDNF Val66 Met polymorphism is associated with body mass index in healthy adults. Neuropsychobiology 53:153–156CrossRefPubMed Gunstad J, Schofield P, Paul RH et al (2006) BDNF Val66 Met polymorphism is associated with body mass index in healthy adults. Neuropsychobiology 53:153–156CrossRefPubMed
16.
go back to reference Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31:303–309CrossRef Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31:303–309CrossRef
17.
go back to reference Resta O, Bonfitto P, Sabato R et al (2004) Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. Diabetes Nutr Metab 17:296–303PubMed Resta O, Bonfitto P, Sabato R et al (2004) Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. Diabetes Nutr Metab 17:296–303PubMed
18.
go back to reference Namyslowski G, Scierski W, Mrowka-Kata K et al (2005) Sleep study in patients with overweight and obesity. J Physiol Pharmacol 56:59–65PubMed Namyslowski G, Scierski W, Mrowka-Kata K et al (2005) Sleep study in patients with overweight and obesity. J Physiol Pharmacol 56:59–65PubMed
19.
go back to reference Dancey DR, Hanly PJ, Soong C et al (2003) Gender differences in sleep apnea: the role of neck circumference. Chest 123:1544–1550CrossRefPubMed Dancey DR, Hanly PJ, Soong C et al (2003) Gender differences in sleep apnea: the role of neck circumference. Chest 123:1544–1550CrossRefPubMed
20.
go back to reference Shelton KE, Woodson H, Gay S et al (1993) Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 148:462–466CrossRefPubMed Shelton KE, Woodson H, Gay S et al (1993) Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 148:462–466CrossRefPubMed
21.
go back to reference Peppard PE, Young T, Palta M et al (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284:3015–3021CrossRefPubMed Peppard PE, Young T, Palta M et al (2000) Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284:3015–3021CrossRefPubMed
Metadata
Title
The Association of Brain-Derived Neurotrophic Factor Gene Polymorphism with Obstructive Sleep Apnea Syndrome and Obesity
Authors
Mehmet Yüksekkaya
Nuri Tutar
Hakan Büyükoğlan
Munis Dündar
İnsu Yılmaz
İnci Gülmez
Fatma Sema Oymak
Burhan Balta
Keziban Korkmaz
Ramazan Demir
Publication date
01-10-2016
Publisher
Springer US
Published in
Lung / Issue 5/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9894-z

Other articles of this Issue 5/2016

Lung 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.